ESC 365 - Effectiveness and safety of apixaban, dabigatran and warfarin compared to rivaroxaban in non-valvular atrial fibrillation; a Norwegian nationwide cohort study

ESC Premium Access

Effectiveness and safety of apixaban, dabigatran and warfarin compared to rivaroxaban in non-valvular atrial fibrillation; a Norwegian nationwide cohort study

Session: Prevention of thromboembolism and atrial remodelling in atrial fibrillation

Topic: Treatment

Speaker: Doctor O. Rutherford (Sarpsborg, NO)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Ole-Christian Walter Rutherford

Sykehuset Ostfold Kalnes, Sarpsborg (Norway)

0 follower

8 more presentations in this session

Equally high detection rates of atrial fibrillation in patients after a TIA and stroke by systematic ECG monitoring with an implanted device: SPIDER-AF study

Speaker: Doctor F. Goss (Munich, DE)

Non valvular atrial fibrillation, contraindication to anticoagulation or antiplatelet therapy and heart team approach: a single centre experience

Speaker: Doctor A. Graffigna (Trento, IT)

Non-vitamin K antagonist oral anticoagulants are safe and effective alternatives to warfarin across subgroups by renal function: results from Danish registries

Speaker: Doctor A. Nissen Bonde (Gentofte, DK)

High mortality in atrial fibrillation patients suffering ischemic stroke, intracranial hemorrhage or a gastrointestinal bleed and associations with the preceding antithrombotic treatment

Speaker: Professor P. Hjemdahl (Stockholm, SE)

Efficacy and safety of non-vitamin K oral anticoagulants in patients with atrial fibrillation and cancer

Speaker: Doctor I. Cavallari (Rome, IT)

Access the full session

Prevention of thromboembolism and atrial remodelling in atrial fibrillation

Speakers: Doctor O. Rutherford, Doctor F. Goss, Doctor A. Graffigna, Doctor A. Nissen Bonde, Professor P. Hjemdahl...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources